Integrated Process for Schizochytrium Oil Extraction, Enzymatic Modification of Lipids and Concentration of DHA Fatty Acid Esters Using Alternative Methodologies

Gonzalo Berzal,Paz García-García,Francisco Javier Señoráns

DOI: https://doi.org/10.3390/md22040146

2024-03-27

Marine Drugs

Abstract:Marine microalgae Schizochytrium sp. have a high content of docosahexaenoic acid (DHA), an omega-3 fatty acid that is attracting interest since it prevents certain neurodegenerative diseases. The obtention of a bioactive and purified DHA fatty acid ester using a whole-integrated process in which renewable sources and alternative methodologies are employed is the aim of this study. For this reason, lyophilized Schizochytrium biomass was used as an alternative to fish oil, and advanced extraction techniques as well as enzymatic modification were studied. Microalgal oil extraction was optimized via a surface-response method using pressurized liquid extraction (PLE) obtaining high oil yields (29.06 ± 0.12%) with a high concentration of DHA (51.15 ± 0.72%). Then, the enzymatic modification of Schizochytrium oil was developed by ethanolysis using immobilized Candida antarctica B lipase (Novozym® 435) at two reaction temperatures and different enzymatic loads. The best condition (40 °C and 200 mg of lipase) produced the highest yield of fatty acid ethyl ester (FAEE) (100%) after 8 h of a reaction attaining a cost-effective and alternative process. Finally, an enriched and purified fraction containing DHA-FAEE was obtained using open-column chromatography with a remarkably high concentration of 93.2 ± 1.3% DHA. The purified and bioactive molecules obtained in this study can be used as nutraceutical and active pharmaceutical intermediates of marine origin.

pharmacology & pharmacy,chemistry, medicinal

What problem does this paper attempt to address?

This paper aims to solve the problems of extraction, enzymatic modification and concentration of docosahexaenoic acid (DHA) fatty acid esters from the marine microalgae Schizochytrium sp. Specifically, the research objective is to obtain bioactive purified DHA fatty acid esters through an overall integrated process, using renewable resources and alternative methods. For this purpose, freeze - dried Schizochytrium biomass was used as a substitute for fish oil, and advanced extraction techniques and enzymatic modification were studied. The following are the specific problems solved in the paper:

1. **High - efficiency extraction of microalgae oil**:
- The method of extracting oil from Schizochytrium using pressurized liquid extraction (PLE) technology was optimized, and microalgae oil with a high yield (29.06 ± 0.12%) and high DHA content (51.15 ± 0.72%) was obtained.

2. **Enzymatic modification of microalgae oil**:
- The Schizochytrium oil was enzymatically modified by ethanolysis reaction using immobilized Candida antarctica B lipase (Novozym®435). The effects of different reaction temperatures (30°C and 40°C) and different enzyme loadings were studied, and it was found that the optimal conditions (40°C and 200 mg lipase) achieved a 100% fatty acid ethyl ester (FAEE) yield within 8 hours.

3. **Concentration of DHA fatty acid esters**:
- Open - column chromatography was used to separate and purify DHA - FAEE, and finally a concentrate with a DHA content as high as 93.2 ± 1.3% was obtained.

In summary, through a series of optimized extraction, enzymatic modification and purification steps, this paper successfully obtained high - purity DHA fatty acid esters from Schizochytrium sp., and these products can be used in nutritional supplements or functional foods for preventing neurodegenerative diseases.